The cell adhesion nectin-like molecules (Necl) 1 and 4 suppress the growth and tumorigenic ability of colon cancer cells.

PubWeight™: 0.84‹?›

🔗 View Article (PMID 19565570)

Published in J Cell Biochem on September 01, 2009

Authors

Shani Raveh1, Nancy Gavert, Ivo Spiegel, Avri Ben-Ze'ev

Author Affiliations

1: Department of Molecular Cell Biology, The Weizmann Institute of Science, Rehovot 76100, Israel.

Articles by these authors

The cadherin-catenin adhesion system in signaling and cancer. J Clin Invest (2002) 3.23

Autoregulation of E-cadherin expression by cadherin-cadherin interactions: the roles of beta-catenin signaling, Slug, and MAPK. J Cell Biol (2003) 3.09

Gliomedin mediates Schwann cell-axon interaction and the molecular assembly of the nodes of Ranvier. Neuron (2005) 2.63

L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers. J Cell Biol (2005) 2.39

Fascin, a novel target of beta-catenin-TCF signaling, is expressed at the invasive front of human colon cancer. Cancer Res (2007) 2.26

Epithelial-mesenchymal transition and the invasive potential of tumors. Trends Mol Med (2008) 2.07

beta-Catenin signaling in biological control and cancer. J Cell Biochem (2007) 1.89

IKKalpha regulates mitogenic signaling through transcriptional induction of cyclin D1 via Tcf. Mol Biol Cell (2003) 1.86

Targeted activation of beta-catenin signaling in basal mammary epithelial cells affects mammary development and leads to hyperplasia. Development (2004) 1.58

Regulation of S33/S37 phosphorylated beta-catenin in normal and transformed cells. J Cell Sci (2002) 1.50

Nr-CAM is a target gene of the beta-catenin/LEF-1 pathway in melanoma and colon cancer and its expression enhances motility and confers tumorigenesis. Genes Dev (2002) 1.50

Expression of L1-CAM and ADAM10 in human colon cancer cells induces metastasis. Cancer Res (2007) 1.46

L1 cell adhesion molecule (L1CAM) in invasive tumors. Cancer Lett (2009) 1.25

SKI activates Wnt/beta-catenin signaling in human melanoma. Cancer Res (2003) 1.22

Prototypical type I E-cadherin and type II cadherin-7 mediate very distinct adhesiveness through their extracellular domains. J Biol Chem (2005) 1.20

L1-CAM in cancerous tissues. Expert Opin Biol Ther (2008) 1.19

Nuclear factor-kappaB signaling and ezrin are essential for L1-mediated metastasis of colon cancer cells. J Cell Sci (2010) 1.15

Downregulation of beta-catenin by p53 involves changes in the rate of beta-catenin phosphorylation and Axin dynamics. Oncogene (2004) 1.13

Retracted Regulation of p53: intricate loops and delicate balances. Biochem Pharmacol (2002) 1.05

Identification of Tmem10/Opalin as an oligodendrocyte enriched gene using expression profiling combined with genetic cell ablation. Glia (2008) 1.01

The cytoskeletal adapter protein 4.1G organizes the internodes in peripheral myelinated nerves. J Cell Biol (2012) 1.00

The shed ectodomain of Nr-CAM stimulates cell proliferation and motility, and confers cell transformation. Cancer Res (2005) 0.97

L1-mediated colon cancer cell metastasis does not require changes in EMT and cancer stem cell markers. Mol Cancer Res (2010) 0.95

PML is a target gene of beta-catenin and plakoglobin, and coactivates beta-catenin-mediated transcription. Cancer Res (2002) 0.94

Novel expression of N-cadherin elicits in vitro bladder cell invasion via the Akt signaling pathway. Oncogene (2004) 0.92

Genetic deletion of Cadm4 results in myelin abnormalities resembling Charcot-Marie-Tooth neuropathy. J Neurosci (2013) 0.89

The phosphatidylinositol-transfer protein Nir2 binds phosphatidic acid and positively regulates phosphoinositide signalling. EMBO Rep (2013) 0.86

Targeting the active beta-catenin pathway to treat cancer cells. Mol Cancer Ther (2006) 0.86

c-Kit is suppressed in human colon cancer tissue and contributes to L1-mediated metastasis. Cancer Res (2013) 0.84

Coordinating changes in cell adhesion and phenotype during EMT-like processes in cancer. F1000 Biol Rep (2010) 0.81

Laparoscopic adjustable gastric banding surgery for morbid obesity: imaging of normal anatomic features and postoperative gastrointestinal complications. AJR Am J Roentgenol (2007) 0.79

Bariatric surgery in adolescence. J Pediatr Surg (2003) 0.79

Apolipoprotein-E genotype and the risk of developing cholelithiasis following bariatric surgery: a clue to prevention of routine prophylactic cholecystectomy. Obes Surg (2002) 0.77